These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 16453335

  • 1. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study.
    Gurney JG, Ness KK, Rosenthal J, Forman SJ, Bhatia S, Baker KS.
    Cancer; 2006 Mar 15; 106(6):1402-8. PubMed ID: 16453335
    [Abstract] [Full Text] [Related]

  • 2. Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study.
    Ness KK, Bhatia S, Baker KS, Francisco L, Carter A, Forman SJ, Robison LL, Rosenthal J, Gurney JG.
    Arch Pediatr Adolesc Med; 2005 Aug 15; 159(8):706-13. PubMed ID: 16061776
    [Abstract] [Full Text] [Related]

  • 3. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
    Cohen A, Rovelli A, Merlo DF, van Lint MT, Lanino E, Bresters D, Ceppi M, Bocchini V, Tichelli A, Socié G.
    J Clin Oncol; 2007 Jun 10; 25(17):2449-54. PubMed ID: 17557958
    [Abstract] [Full Text] [Related]

  • 4. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A, Passweg J, Wójcik D, Rovó A, Harousseau JL, Masszi T, Zander A, Békássy A, Crawley C, Arat M, Sica S, Lutz P, Socié G, EBMT Late Effects Working Party.
    Haematologica; 2008 Aug 10; 93(8):1203-10. PubMed ID: 18556401
    [Abstract] [Full Text] [Related]

  • 5. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I, Porcher R, Robin M, de Latour RP, Glotz D, Socié G, Peraldi MN.
    Biol Blood Marrow Transplant; 2009 Oct 10; 15(10):1251-7. PubMed ID: 19747632
    [Abstract] [Full Text] [Related]

  • 6. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study.
    Bresters D, van Gils IC, Kollen WJ, Ball LM, Oostdijk W, van der Bom JG, Egeler RM.
    Bone Marrow Transplant; 2010 Jan 10; 45(1):79-85. PubMed ID: 19421172
    [Abstract] [Full Text] [Related]

  • 7. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
    Al-Hazzouri A, Cao Q, Burns LJ, Weisdorf DJ, Majhail NS.
    Biol Blood Marrow Transplant; 2008 Jun 10; 14(6):658-63. PubMed ID: 18489991
    [Abstract] [Full Text] [Related]

  • 8. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation.
    Bailey HK, Kappy MS, Giller RH, Gralla J.
    Pediatr Blood Cancer; 2008 Sep 10; 51(3):405-9. PubMed ID: 18523993
    [Abstract] [Full Text] [Related]

  • 9. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.
    Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR.
    J Clin Oncol; 2005 Jan 20; 23(3):599-608. PubMed ID: 15659507
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Biol Blood Marrow Transplant; 2008 Jun 20; 14(6):651-7. PubMed ID: 18489990
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.
    Biol Blood Marrow Transplant; 2009 Jan 20; 15(1):30-8. PubMed ID: 19135940
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M, Porcher R, De Castro Araujo R, de Latour RP, Devergie A, Rocha V, Larghero J, Adès L, Ribaud P, Mary JY, Socié G.
    Biol Blood Marrow Transplant; 2007 Nov 20; 13(11):1304-12. PubMed ID: 17950917
    [Abstract] [Full Text] [Related]

  • 13. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
    Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F, Nysom K, Galambrun C, Fagioli F, Varotto S, Messina C, Verdeguer A, Urban C, Faraci M, Dini G, Fedeli S, Tichelli A, Rovelli A, Socié G.
    Bone Marrow Transplant; 2007 Jun 20; 39(11):667-75. PubMed ID: 17401396
    [Abstract] [Full Text] [Related]

  • 14. Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases.
    Somali M, Mpatakoias V, Avramides A, Sakellari I, Kaloyannidis P, Smias C, Anagnostopoulos A, Kourtis A, Rousso D, Panidis D, Vagenakis A.
    Gynecol Endocrinol; 2005 Jul 20; 21(1):18-26. PubMed ID: 16048797
    [Abstract] [Full Text] [Related]

  • 15. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
    Majhail NS, Challa TR, Mulrooney DA, Baker KS, Burns LJ.
    Biol Blood Marrow Transplant; 2009 Sep 20; 15(9):1100-7. PubMed ID: 19660723
    [Abstract] [Full Text] [Related]

  • 16. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant.
    Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M, Foppiano F, Sacco O, Cabria M, De Marco R, Stella G, Dallorso S, Bagnasco F, Vitale V, Dini G, Haupt R.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1568-75. PubMed ID: 15990246
    [Abstract] [Full Text] [Related]

  • 17. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 01; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 18. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes.
    Majhail NS, Parks K, Defor TE, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2006 Oct 01; 12(10):1038-46. PubMed ID: 17067910
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years.
    Künkele A, Engelhard M, Hauffa BP, Mellies U, Müntjes C, Hüer C, Eggert A, Schulte JH, Kremens B.
    Pediatr Blood Cancer; 2013 Nov 01; 60(11):1792-7. PubMed ID: 23893964
    [Abstract] [Full Text] [Related]

  • 20. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients.
    Ouachée-Chardin M, Elie C, de Saint Basile G, Le Deist F, Mahlaoui N, Picard C, Neven B, Casanova JL, Tardieu M, Cavazzana-Calvo M, Blanche S, Fischer A.
    Pediatrics; 2006 Apr 01; 117(4):e743-50. PubMed ID: 16549504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.